Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2.
In conclusion, our study demonstrates a novel mechanism by which arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 and PKM2 negatively regulating MEG3.
PMID: 31003765 [PubMed - as supplied by publisher]
Source: Biochemical and Biophysical Research communications - Category: Biochemistry Authors: Fan Z, He J, Fu T, Zhang W, Yang G, Qu X, Liu R, Lv L, Wang J Tags: Biochem Biophys Res Commun Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Epithelial Cancer | Genetics | Hepatocellular Carcinoma | Liver Cancer | Science | Study